Article
Analgesic pharmacotherapy costs, regimen, and impact on postoperative pain-related functioning
Kosten, Behandlungsschema und Auswirkungen der analgetischen Pharmakotherapie auf die postoperative Schmerzfunktion
Search Medline for
Authors
Published: | June 4, 2021 |
---|
Outline
Text
Objective: To analyze the impact of analgesic pharmacotherapy used after spine surgery on subjective quality of life and pain relief of patients with lumbar degenerative vertebral disc disease.
Methods: Fifty patients with LDVDD in L5/S1 and L4/L5 spine section who were qualified for spine surgery were recruited into this study.
The outcomes of postoperative pain and functional outcomes were recorded using standarised questionnaires.
Results: The greatest improvement in functioning between baseline and follow-up measurements was observed in the group of patients treated with non-opioids. Total average pharmacotherapy cost amounted to EUR 453.42 (±49.09).
Conclusion: This study supports the notion that pain pharmacotherapies could potentially be differentiated in terms of overall impact on quality of life, and that pain-related distress might be the most relevant driver of quality of life in this setting.